Ads
related to: atomoxetine for adhd in children
Search results
Results from the WOW.Com Content Network
Atomoxetine is sometimes used in the treatment of cognitive impairment and frontal lobe symptoms due to conditions like traumatic brain injury (TBI). [48] [49] It is used to treat ADHD-like symptoms such as sustained attentional problems, disinhibition, [50] lack of arousal, fatigue, and depression, including symptoms from cognitive disengagement syndrome. [48]
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Strattera (atomoxetine) Intuniv (guanfacine) Kapvay (clonidine) Non-stimulant medications are recommended for the 15-30% of children with ADHD who don't respond to stimulants, ...
One in four U.S. adults suspects they may have ADHD and drugs are a first line of treatment for this condition. ... (brand names Ritalin, Concerta), a stimulant, and atomoxetine (Strattera), a non ...
Atomoxetine is sold under the brand name Strattera and was first approved for medical use in the United States in 2002. [1] Its indication is for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents and adults. [2]
Ads
related to: atomoxetine for adhd in children